CAS NO: | 2444308-95-4 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
生物活性 | Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain ofSARS-CoV-2spike protein, blocking interaction withACE2for viral entry. Regdanvimab can be used for the research of COVID-19[1]. | ||||||||
IC50& Target | SARS-CoV-2, ACE2[1] | ||||||||
体外研究 (In Vitro) | Regdanvimab (CT-P59) (0-1000 ng/mL; 72 h) can neutralize Gamma, Delta and Epsilon variants with IC50s of 161.5-1237 ng/mL[1]. | ||||||||
体内研究 (In Vivo) | Regdanvimab (CT-P59) (5-80 mg/kg; i.p.; single dose) 可以降低小鼠 Gamma 和 Delta 株的病毒负担[1]。
| ||||||||
CAS 号 | 2444308-95-4 | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |